Redefining Spinal Cord Stimulation “Trials”: A Randomized Controlled Trial Using Single‐Stage Wireless Permanent Implantable Devices

ConclusionUsing wireless SCS devices that allow for an extended trial period and evaluation of various waveforms, we observed a high rate trial success rate with both HFS and LFS waveforms, with minimal incidence of infection. Long ‐term follow‐up will address the cost‐effectiveness and morbidity associated with this technology, which facilitates single‐stage treatment.

Source: Neuromodulation: Technology at the Neural Interface - June 2, 2019 Category: Biotechnology Authors: Richard B. North, Aaron Calodney, Robert Bolash, Konstantin V. Slavin, Michael Creamer, Richard Rauck, Payam Vahedifar, Ira Fox, Cuneyt Özaktay, Sunil Panchal, Niek Vanquathem Tags: Clinical Research Source Type: research